Alexandre Fioranelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandre Fioranelli has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Nelson Wolosker
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
13 shared publications - Marcelo Fiorelli Alexandrino da Silva
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
10 shared publications - Marcelo Passos Teivelis
Hospital Israelita Albert Einstein, Brazil; Faculdade Israelita de Ciências da Saúde Albert Einstein, Brazil
10 shared publications - Felipe Soares Oliveira Portela
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
6 shared publications - Bruno Jeronimo Ponte
Hospital Israelita Albert Einstein
5 shared publications - Maria Fernanda Cassino Portugal
Department of Vascular Surgery, Hospital Israelita Albert Einstein
5 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 25, e20250108
Evaluation of a clinical score to predict post-sclerotherapy hyperpigmentation compared with the Skin Hyperpigmentation Index: a prospective Skin Code study
Post-sclerotherapy hyperpigmentation (PSH) is a common complication following sclerotherapy for telangiectasias and reticular veins. However, tools for pre-procedural prediction of PSH are limited, making pre-treatment identification of patients at greater risk a challenge. This research aimed to evaluate a clinical scoring system (Skin Code Score) designed to estimate the individual risk of PSH. A prospective, single-center, single-arm study was conducted. Adult female patients with telangiectasias and reticular veins were treated and evaluated for pigmentation risk using the Skin Code Score (range, 2-12 points). Hyperpigmentation was assessed at baseline and on day 30 by in-person evaluation performed by one vascular surgeon, complemented by photographic analysis conducted independently by two other vascular surgeons and one dermatologist. Skin Hyperpigmentation Index (SHI) measurements were used for objective correlation with the Skin Code Score. The Skin Code Score showed strong interobserver agreement and reproducibility (κ ≥ 0.85). Diagnostic accuracy ranged from 82.8% to 94.7% among evaluators. A score of 12 predicted PSH in up to 99.8% of cases, while a score of 8 indicated a probability of approximately 76%. The study was limited by a small sample size and its single-center design; a proportion of the assessments were conducted by photographic analysis. It is concluded that the Skin Code Score is a simple and reproducible tool for predicting PSH and could assist clinicians with pre-procedural risk stratification, patient counseling, and clinical decision-making.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 25, e20250108
Open AccessEvaluation of a clinical score to predict post-sclerotherapy hyperpigmentation compared with the Skin Hyperpigmentation Index: a prospective Skin Code study
Post-sclerotherapy hyperpigmentation (PSH) is a common complication following sclerotherapy for telangiectasias and reticular veins. However, tools for pre-procedural prediction of PSH are limited, making pre-treatment identification of patients at greater risk a challenge. This research aimed to evaluate a clinical scoring system (Skin Code Score) designed to estimate the individual risk of PSH. A prospective, single-center, single-arm study was conducted. Adult female patients with telangiectasias and reticular veins were treated and evaluated for pigmentation risk using the Skin Code Score (range, 2-12 points). Hyperpigmentation was assessed at baseline and on day 30 by in-person evaluation performed by one vascular surgeon, complemented by photographic analysis conducted independently by two other vascular surgeons and one dermatologist. Skin Hyperpigmentation Index (SHI) measurements were used for objective correlation with the Skin Code Score. The Skin Code Score showed strong interobserver agreement and reproducibility (κ ≥ 0.85). Diagnostic accuracy ranged from 82.8% to 94.7% among evaluators. A score of 12 predicted PSH in up to 99.8% of cases, while a score of 8 indicated a probability of approximately 76%. The study was limited by a small sample size and its single-center design; a proportion of the assessments were conducted by photographic analysis. It is concluded that the Skin Code Score is a simple and reproducible tool for predicting PSH and could assist clinicians with pre-procedural risk stratification, patient counseling, and clinical decision-making.
- Open Access
Analysis of all video-assisted thoracic sympathectomy over 9 years in Brazil: trends, costs and mortality over 200 million inhabitants
Background: Hyperhidrosis (HH) is characterized by excessive sweating beyond thermoregulatory requirements and can significantly impair quality of life. Although oxybutynin has become an effective first-line therapy, video-assisted thoracic sympathectomy (VATS) remains the only definitive option for refractory cases. The availability of nationwide public and private healthcare datasets in Brazil enables a comprehensive assessment of national procedural trends on a continental scale. Methods: We performed a retrospective nationwide analysis of all VATS procedures for HH conducted in Brazil between 2015 and 2023. Data were extracted from publicly available governmental databases covering both the public and private healthcare systems. Procedure rates were evaluated by year, geographic region, sex, and age group. Temporal patterns and differences between healthcare sectors were analyzed. Results: A total of 26,980 VATS procedures were performed during the study period, with the private sector accounting for 75.25% of surgeries. Regionally, the Southeast (48.28%) and South (29.51%)—the most economically developed areas of the country—concentrated the majority of procedures. Women represented 64.5% of operated patients, and most surgeries were performed in individuals aged 15–39 years (82.74%). The mean cost per procedure in the private system was 4.2 times higher than in the public system (US$1,351.94 vs. US$351.27, p < 0.001), and the private sector accounted for more than 90% of total national expenditures. The overall mortality rate was 0.048%, with no significant difference between healthcare sectors. Conclusions: This study provides the first nationwide evaluation of VATS performed for HH across Brazil’s public and private systems. Based on 26,980 procedures carried out between 2015 and 2023, most surgeries occurred in the private sector and predominantly involved women and young adults aged 15–39 years. Although mortality was low and similar across systems, procedure costs were substantially higher in the private sector, which accounted for the vast majority of national expenditures.
Open AccessAnalysis of all video-assisted thoracic sympathectomy over 9 years in Brazil: trends, costs and mortality over 200 million inhabitants
Background: Hyperhidrosis (HH) is characterized by excessive sweating beyond thermoregulatory requirements and can significantly impair quality of life. Although oxybutynin has become an effective first-line therapy, video-assisted thoracic sympathectomy (VATS) remains the only definitive option for refractory cases. The availability of nationwide public and private healthcare datasets in Brazil enables a comprehensive assessment of national procedural trends on a continental scale. Methods: We performed a retrospective nationwide analysis of all VATS procedures for HH conducted in Brazil between 2015 and 2023. Data were extracted from publicly available governmental databases covering both the public and private healthcare systems. Procedure rates were evaluated by year, geographic region, sex, and age group. Temporal patterns and differences between healthcare sectors were analyzed. Results: A total of 26,980 VATS procedures were performed during the study period, with the private sector accounting for 75.25% of surgeries. Regionally, the Southeast (48.28%) and South (29.51%)—the most economically developed areas of the country—concentrated the majority of procedures. Women represented 64.5% of operated patients, and most surgeries were performed in individuals aged 15–39 years (82.74%). The mean cost per procedure in the private system was 4.2 times higher than in the public system (US$1,351.94 vs. US$351.27, p < 0.001), and the private sector accounted for more than 90% of total national expenditures. The overall mortality rate was 0.048%, with no significant difference between healthcare sectors. Conclusions: This study provides the first nationwide evaluation of VATS performed for HH across Brazil’s public and private systems. Based on 26,980 procedures carried out between 2015 and 2023, most surgeries occurred in the private sector and predominantly involved women and young adults aged 15–39 years. Although mortality was low and similar across systems, procedure costs were substantially higher in the private sector, which accounted for the vast majority of national expenditures.
- Open Access
Epidemiology of 376,383 arteriovenous fistula creations for hemodialysis over 9 years within the Brazilian Unified Public Health System and the Private Healthcare Sector
Background: Chronic kidney disease (CKD) represents a growing public health challenge worldwide, particularly in low- and middle-income countries. In Brazil, where most patients with end-stage renal disease (ESRD) depend on the public healthcare system for dialysis and transplantation, ensuring adequate vascular access - among the options arteriovenous fistula (AVF) - is critical to sustaining treatment. Despite its clinical relevance, comprehensive national data on vascular access patterns across both public and private sectors have been historically limited. Objective: This study aimed to examine trends in AVF confection for hemodialysis across Brazil from 2015 to 2023, assessing differences in frequency, geographic distribution and sectorial disparities between the public and the private healthcare sector. Methods: A retrospective population-based analysis was conducted using anonymized data from national administrative databases: DATASUS (public sector) and D-TISS (private sector). The majority of AVF confection procedures were included. Statistical analyses considered regional adjustments and were performed using SPSS v.20, with significance set at p < 0.001. Results: Over the nine-year period, 376.383 AVF procedures were recorded, with 90,57% occurring in the public sector. While the absolute number of AVF confectioners increased, the ratio of AVFs per 1,000 dialysis patients showed a declining trend. Regional disparities were evident, with the Southeast and South regions presenting higher procedure rates compared to other areas. The private sector consistently reported lower confection rates. Conclusion: Although, separately, dialysis and AVFs rates have risen steadily in Brazil, the relative rate between than has decreasing trend over the years. The predominance of AVF procedures in the public system maintains higher when compared with the private sector.
Open AccessEpidemiology of 376,383 arteriovenous fistula creations for hemodialysis over 9 years within the Brazilian Unified Public Health System and the Private Healthcare Sector
Background: Chronic kidney disease (CKD) represents a growing public health challenge worldwide, particularly in low- and middle-income countries. In Brazil, where most patients with end-stage renal disease (ESRD) depend on the public healthcare system for dialysis and transplantation, ensuring adequate vascular access - among the options arteriovenous fistula (AVF) - is critical to sustaining treatment. Despite its clinical relevance, comprehensive national data on vascular access patterns across both public and private sectors have been historically limited. Objective: This study aimed to examine trends in AVF confection for hemodialysis across Brazil from 2015 to 2023, assessing differences in frequency, geographic distribution and sectorial disparities between the public and the private healthcare sector. Methods: A retrospective population-based analysis was conducted using anonymized data from national administrative databases: DATASUS (public sector) and D-TISS (private sector). The majority of AVF confection procedures were included. Statistical analyses considered regional adjustments and were performed using SPSS v.20, with significance set at p < 0.001. Results: Over the nine-year period, 376.383 AVF procedures were recorded, with 90,57% occurring in the public sector. While the absolute number of AVF confectioners increased, the ratio of AVFs per 1,000 dialysis patients showed a declining trend. Regional disparities were evident, with the Southeast and South regions presenting higher procedure rates compared to other areas. The private sector consistently reported lower confection rates. Conclusion: Although, separately, dialysis and AVFs rates have risen steadily in Brazil, the relative rate between than has decreasing trend over the years. The predominance of AVF procedures in the public system maintains higher when compared with the private sector.
- Open Access
Epidemiological analysis of all vena cava filter placement over 9 years in Brazil: trends and mortality rates in a population of over 200 million
Background: Venous thromboembolism (VTE) is a major global health concern, with inferior vena cava filters (VCFs) serving as an alternative to anticoagulation in high-risk patients. Brazil’s VCF trends remain understudied, particularly in its dual public-private healthcare system. This database study allows a broad overview of the Brazilian healthcare landscape. Methods: This retrospective nationwide analysis used Brazilian public (SUS/TabNet) and private (ANS/D-TISS) healthcare databases (2015–2023) to assess VCF placement rates, regional disparities and in-hospital mortality. Data included 21,630 procedures, analyzed via generalized linear models (Gamma/Poisson distributions). Results: The private system performed 57% of VCFs (12,323) despite covering only 25% of the population, with a 4.25-fold higher procedure rate per capita than the public system (29.45 vs. 6.42 per million). Women accounted for 57.8% of recipients. The Southeast region dominated (70% private, 40.5% public), while the North and Midwest had the lowest rates. Mortality rates were comparable (public 6.7% vs. private 7.4%, p = 0.066), peaking during COVID-19. Procedure volumes rose 140% over 9 years, contrasting with declining U.S. trends post-FDA restrictions. Conclusions: Brazil’s VCF use reflects systemic inequities, with private-system overrepresentation and regional gaps. This study enables unprecedented insights into large-scale VCF implementation across diverse healthcare subsystems.
Open AccessEpidemiological analysis of all vena cava filter placement over 9 years in Brazil: trends and mortality rates in a population of over 200 million
Background: Venous thromboembolism (VTE) is a major global health concern, with inferior vena cava filters (VCFs) serving as an alternative to anticoagulation in high-risk patients. Brazil’s VCF trends remain understudied, particularly in its dual public-private healthcare system. This database study allows a broad overview of the Brazilian healthcare landscape. Methods: This retrospective nationwide analysis used Brazilian public (SUS/TabNet) and private (ANS/D-TISS) healthcare databases (2015–2023) to assess VCF placement rates, regional disparities and in-hospital mortality. Data included 21,630 procedures, analyzed via generalized linear models (Gamma/Poisson distributions). Results: The private system performed 57% of VCFs (12,323) despite covering only 25% of the population, with a 4.25-fold higher procedure rate per capita than the public system (29.45 vs. 6.42 per million). Women accounted for 57.8% of recipients. The Southeast region dominated (70% private, 40.5% public), while the North and Midwest had the lowest rates. Mortality rates were comparable (public 6.7% vs. private 7.4%, p = 0.066), peaking during COVID-19. Procedure volumes rose 140% over 9 years, contrasting with declining U.S. trends post-FDA restrictions. Conclusions: Brazil’s VCF use reflects systemic inequities, with private-system overrepresentation and regional gaps. This study enables unprecedented insights into large-scale VCF implementation across diverse healthcare subsystems.
- Open Access
Epidemiological analysis of all varicose vein surgeries over 9 years in Brazil: trends, costs and mortality rate of 1,266,550 cases
2 Objectives: To evaluate the total number of surgical procedures for varicose vein treatment performed within the Brazilian Unified Public Health System (SUS) and the Private Health System (PHS) between 2015 and 2023 and to analyze their differences regarding the number of procedures over time, financial investments, and in-hospital mortality rates. Materials and Methods: Data on varicose vein surgeries performed between 2015 and 2023 were extracted from the SUS database and the procedural code table provided by the National Supplementary Health Agency (ANS), which reports procedures conducted within the PHS in Brazil. The data included geographic region, number of procedures performed, in-hospital mortality (reported only by SUS), and the amount invested by the government and private health insurance providers. Results: A total of 1,266,550 varicose vein surgeries were performed in both public and supplementary healthcare systems in Brazil between 2015 and 2023, with an average surgery rate per 10,000 inhabitants per year of 3.7 in SUS and 14.8 in PHS. The total financial investment amounted to BRL 1,492,310,372.13, with an overall average cost per procedure of BRL 1,240.92. The mean cost per procedure in SUS was BRL 679.50, whereas in PHS, it was BRL 1,632.60—approximately 3.15 times higher than in SUS. A total of 29 in-hospital deaths were recorded in SUS after varicose vein surgery, representing an overall mortality rate of 0.005%. Conclusions: A total of 1,266,550 surgeries were performed between 2015 and 2023 for chronic venous disease treatment, with a rate of 6.5 procedures per 10,000 inhabitants per year. In the PHS system, the number of surgeries was four times higher than in SUS, considering the number of procedures per 10,000 inhabitants. The total investment in PHS was 3.15 times greater than in SUS, with an estimated average cost per procedure of BRL 1,632.60. The observed in-hospital mortality rate in SUS was 0.005%.
Open AccessEpidemiological analysis of all varicose vein surgeries over 9 years in Brazil: trends, costs and mortality rate of 1,266,550 cases
2 Objectives: To evaluate the total number of surgical procedures for varicose vein treatment performed within the Brazilian Unified Public Health System (SUS) and the Private Health System (PHS) between 2015 and 2023 and to analyze their differences regarding the number of procedures over time, financial investments, and in-hospital mortality rates. Materials and Methods: Data on varicose vein surgeries performed between 2015 and 2023 were extracted from the SUS database and the procedural code table provided by the National Supplementary Health Agency (ANS), which reports procedures conducted within the PHS in Brazil. The data included geographic region, number of procedures performed, in-hospital mortality (reported only by SUS), and the amount invested by the government and private health insurance providers. Results: A total of 1,266,550 varicose vein surgeries were performed in both public and supplementary healthcare systems in Brazil between 2015 and 2023, with an average surgery rate per 10,000 inhabitants per year of 3.7 in SUS and 14.8 in PHS. The total financial investment amounted to BRL 1,492,310,372.13, with an overall average cost per procedure of BRL 1,240.92. The mean cost per procedure in SUS was BRL 679.50, whereas in PHS, it was BRL 1,632.60—approximately 3.15 times higher than in SUS. A total of 29 in-hospital deaths were recorded in SUS after varicose vein surgery, representing an overall mortality rate of 0.005%. Conclusions: A total of 1,266,550 surgeries were performed between 2015 and 2023 for chronic venous disease treatment, with a rate of 6.5 procedures per 10,000 inhabitants per year. In the PHS system, the number of surgeries was four times higher than in SUS, considering the number of procedures per 10,000 inhabitants. The total investment in PHS was 3.15 times greater than in SUS, with an estimated average cost per procedure of BRL 1,632.60. The observed in-hospital mortality rate in SUS was 0.005%.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (2) , e20240608
Temporal trend in venous thromboembolism hospitalization rates in Brazil
OBJECTIVE: Venous thromboembolism is a condition of great interest to public health, as it is potentially preventable and has a high morbidity and mortality potential. Knowing the real-world data in a country of continental dimensions such as Brazil is essential to help define health policies that enable proper diagnosis and treatment of this disease. The objective of this study was to evaluate the incidence and in-hospital mortality rates of venous thromboembolism in public hospitals under Brazil's public health system.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (2) , e20240608
Open AccessTemporal trend in venous thromboembolism hospitalization rates in Brazil
OBJECTIVE: Venous thromboembolism is a condition of great interest to public health, as it is potentially preventable and has a high morbidity and mortality potential. Knowing the real-world data in a country of continental dimensions such as Brazil is essential to help define health policies that enable proper diagnosis and treatment of this disease. The objective of this study was to evaluate the incidence and in-hospital mortality rates of venous thromboembolism in public hospitals under Brazil's public health system.
- Open Access
Polidocanol-foam treatment of varicose veins: Quality-of-life impact compared to conventional surgery
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20230040
Brazilian Society for Angiology and Vascular Surgery guidelines on abdominal aortic aneurysm
The Brazilian Society of Angiology and Vascular Surgery, through the Guidelines Project, presents new Abdominal Aortic Aneurysm Guidelines, on the subject of care for abdominal aortic aneurysm patients. Its development prioritized descriptive guidelines, using the EMBASE, LILACS, and PubMed databases. References include randomized controlled trials, systematic reviews, meta-analyses, and cohort studies. Quality of evidence was evaluated by a pair of coordinators, aided by the RoB 2 Cochrane tool and the Newcastle Ottawa Scale forms. The subjects include juxtarenal aneurysms, infected aneurysms, and new therapeutic techniques, especially endovascular procedures. The current version of the guidelines include important recommendations for the primary topics involving diagnosis, treatment, and follow-up for abdominal aortic aneurysm patients, providing an objective guide for medical practice, based on scientific evidence and widely available throughout Brazil.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20230040
Open AccessBrazilian Society for Angiology and Vascular Surgery guidelines on abdominal aortic aneurysm
The Brazilian Society of Angiology and Vascular Surgery, through the Guidelines Project, presents new Abdominal Aortic Aneurysm Guidelines, on the subject of care for abdominal aortic aneurysm patients. Its development prioritized descriptive guidelines, using the EMBASE, LILACS, and PubMed databases. References include randomized controlled trials, systematic reviews, meta-analyses, and cohort studies. Quality of evidence was evaluated by a pair of coordinators, aided by the RoB 2 Cochrane tool and the Newcastle Ottawa Scale forms. The subjects include juxtarenal aneurysms, infected aneurysms, and new therapeutic techniques, especially endovascular procedures. The current version of the guidelines include important recommendations for the primary topics involving diagnosis, treatment, and follow-up for abdominal aortic aneurysm patients, providing an objective guide for medical practice, based on scientific evidence and widely available throughout Brazil.
- Open Access
- 1 June 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (5) , 747-752
Anxiety and depression scores in patients subjected to aortic and iliac aneurysm repair procedures
OBJECTIVE: This study examines the changes in anxiety and depression scores of 84 patients subjected to aortic or iliac aneurysm correction with no previous psychiatric history. METHODS: Patients were referred to the evaluation using the Beck Anxiety and Depression Inventories no more than 3 days before surgery (i.e., preoperative [Pre-Op]), 30 days after revascularization (i.e., Early postoperative [PO]), and at least 6 months after revascularization (i.e., Late PO). RESULTS: Mean anxiety scores declined from baseline at both the Early (mean difference: 2.75, p0.05, Late PO: 0.87, p=0.05). A more severe degree of anxiety at baseline was related to better anxiety results both in the Early PO (p=0.041) and Late PO (p=0.008). An endovascular technique was related to the improvement in depression symptoms in the Early PO (p=0.01) but the worsening of the symptoms in the Late PO (p=0.033). CONCLUSIONS: Patients subjected to aortoiliac aneurysm corrections have a higher incidence of anxiety and depressive symptoms. Anxiety symptoms, but not the depressive ones, improved considerably following the successful treatment. The formal psychiatric evaluation may be beneficial for patients with less improvement in the symptom.
- 1 June 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (5) , 747-752
Open AccessAnxiety and depression scores in patients subjected to aortic and iliac aneurysm repair procedures
OBJECTIVE: This study examines the changes in anxiety and depression scores of 84 patients subjected to aortic or iliac aneurysm correction with no previous psychiatric history. METHODS: Patients were referred to the evaluation using the Beck Anxiety and Depression Inventories no more than 3 days before surgery (i.e., preoperative [Pre-Op]), 30 days after revascularization (i.e., Early postoperative [PO]), and at least 6 months after revascularization (i.e., Late PO). RESULTS: Mean anxiety scores declined from baseline at both the Early (mean difference: 2.75, p0.05, Late PO: 0.87, p=0.05). A more severe degree of anxiety at baseline was related to better anxiety results both in the Early PO (p=0.041) and Late PO (p=0.008). An endovascular technique was related to the improvement in depression symptoms in the Early PO (p=0.01) but the worsening of the symptoms in the Late PO (p=0.033). CONCLUSIONS: Patients subjected to aortoiliac aneurysm corrections have a higher incidence of anxiety and depressive symptoms. Anxiety symptoms, but not the depressive ones, improved considerably following the successful treatment. The formal psychiatric evaluation may be beneficial for patients with less improvement in the symptom.